Fig. 3
From: Multilayer network analysis of the drugs development cycle in the global pharmaceutical industry
Knowledge flows of drug pipelines between licenser and licensee at country level per pipeline status focused on the top 10 countries in Fig. 1. Each element represents the number of drug pipelines between countries, ignored the drug pipelines whose license has not shifted. The diagonal elements correspond to the number of shifts of licenses between companies in the country